ProPharma Group Recognized by Everest Group as a Major Contender in Life Sciences Operations PEAK Matrix® Assessment 2023
Summary
"We are honored to be named a Major Contender this year, with ProPharma making one of the biggest climbs in placement among all the companies assessed," -ProPharma Group CEO Michael Stomberg. In less than a year after the launch of our Research Consulting Organization model, our team has achieved a number of significant milestones and Im immensely proud that their hard work has been recognized in this way by Everest Group." ProPharma was evaluated by Everest Group alongside 27 other leading global life sciences operations providers based on various parameters encompassing their market adoption, portfolio mix, value delivered, vision and strategy, scope of services offered, innovation and investments, and delivery footprint. As the worlds largest RCO (Research Consulting Organization), ProPharma partners with its clients through an advise-build-operate model across the complete product lifecycle. With deep domain expertise in regulatory sciences, clinical research solutions, quality and compliance, pharmacovigilance, medical information, and R&D technology, ProPharma offers an end-to-end suite of fully customizable consulting solutions that de-risk and accelerate our partners most high-profile drug and device programs.